KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Fulgent Genetics (FLGT) Receivables - Other (2017 - 2025)

Fulgent Genetics' Receivables - Other history spans 10 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Receivables - Other fell 35.86% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, down 35.86%, while the annual FY2025 figure was $1.1 million, 35.86% down from the prior year.
  • Receivables - Other for Q4 2025 was $1.1 million at Fulgent Genetics, down from $1.4 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $19.8 million in Q4 2022 and bottomed at $1000.0 in Q1 2021.
  • The 5-year median for Receivables - Other is $1.1 million (2025), against an average of $2.1 million.
  • The largest annual shift saw Receivables - Other tumbled 96.88% in 2021 before it skyrocketed 23000.0% in 2022.
  • A 5-year view of Receivables - Other shows it stood at $1.4 million in 2021, then soared by 1313.83% to $19.8 million in 2022, then tumbled by 93.35% to $1.3 million in 2023, then skyrocketed by 34.04% to $1.8 million in 2024, then plummeted by 35.86% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Receivables - Other are $1.1 million (Q4 2025), $1.4 million (Q3 2025), and $2.1 million (Q2 2025).